The peritumoral brain zone in glioblastoma: where we are and where we are going
Glioblastoma (GBM) is the most aggressive and invasive primary brain tumor. Current
therapies are not curative, and patients' outcomes remain poor with an overall survival of …
therapies are not curative, and patients' outcomes remain poor with an overall survival of …
Applications of radiomics and radiogenomics in high-grade gliomas in the era of precision medicine
Simple Summary Radiomics and radiogenomics offer new insight into high-grade glioma
biology, as well as into glioma behavior in response to standard therapies. In this article, we …
biology, as well as into glioma behavior in response to standard therapies. In this article, we …
Multi‐ligand functionalized blood‐to‐tumor sequential targeting strategies in the field of glioblastoma nanomedicine
Glioblastoma (GBM) is an unmet clinical need characterized by a standard of care (SOC) 5‐
year survival rate of only 5%, and a treatment mostly palliative. Significant hurdles in GBM …
year survival rate of only 5%, and a treatment mostly palliative. Significant hurdles in GBM …
Current Status and Future Perspective in Glioma Invasion Research
T Ohnishi - Brain Sciences, 2024 - mdpi.com
Glioblastoma (GBM) is the most malignant brain tumor in adults and shows an extremely
poor prognosis, with a median survival of 15 months [1]. The main reason for this poor …
poor prognosis, with a median survival of 15 months [1]. The main reason for this poor …
Amine‐weighted chemical exchange saturation transfer magnetic resonance imaging in brain tumors
Amine‐weighted chemical exchange saturation transfer (CEST) magnetic resonance
imaging (MRI) is particularly valuable as an amine‐and pH‐sensitive imaging technique in …
imaging (MRI) is particularly valuable as an amine‐and pH‐sensitive imaging technique in …
Peritumoral brain zone in glioblastoma: biological, clinical and mechanical features
Glioblastoma is a highly aggressive and invasive tumor that affects the central nervous
system (CNS). With a five-year survival rate of only 6.9% and a median survival time of eight …
system (CNS). With a five-year survival rate of only 6.9% and a median survival time of eight …
Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma
Glioblastoma (GBM) remains the epitome of aggressiveness and lethality in the spectrum of
brain tumors, primarily due to the blood–brain barrier (BBB) that hinders effective treatment …
brain tumors, primarily due to the blood–brain barrier (BBB) that hinders effective treatment …
Differentiation between glioma recurrence and treatment effects using amide proton transfer imaging: A mini-Bayesian bivariate meta-analysis
K Chen, XW Jiang, L Deng, HL She - Frontiers in Oncology, 2022 - frontiersin.org
Background Amide proton transfer (APT) imaging as an emerging MRI approach has been
used for distinguishing tumor recurrence (TR) and treatment effects (TEs) in glioma patients …
used for distinguishing tumor recurrence (TR) and treatment effects (TEs) in glioma patients …
[HTML][HTML] The peritumoral brain zone in glioblastoma: a review of the pretreatment approach
A Michalska-Foryszewska, M Bujko… - Polish Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Glioblastomas are the most common and aggressive form of malignant primary brain tumors
in adults. The standard treatment is surgical resection followed by radiotherapy and …
in adults. The standard treatment is surgical resection followed by radiotherapy and …
Functional biomaterials for biomimetic 3D in vitro tumor microenvironment modeling
T Ahmed - In vitro models, 2023 - Springer
The translational potential of promising anticancer medications and treatments may be
enhanced by the creation of 3D in vitro models that can accurately reproduce native tumor …
enhanced by the creation of 3D in vitro models that can accurately reproduce native tumor …